BOSTON SCIENTIFIC CORP (BSX) Cash flow
Market cap
$94.1B
P/E ratio
32.7x
| 2010/12 | 2011/12 | 2012/12 | 2013/12 | 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | 2025/12 | |
| Depreciation & amortization | - | 717 | 683 | 689 | 725 | 769 | 815 | 844 | 894 | 1,011 | 1,123 | 1,093 | 1,136 | 1,196 | 1,269 | 1,368 |
| Stock-based compensation | 150 | 128 | 108 | 105 | 103 | 107 | 116 | 127 | 140 | 157 | 170 | 194 | 220 | 233 | 266 | 299 |
| Cash from operations | 325 | 1,008 | 1,260 | 1,082 | 1,269 | 600 | 972 | 1,426 | 310 | 1,836 | 1,508 | 1,870 | 1,526 | 2,503 | 3,435 | 4,534 |
| Capital expenditures | -272 | -304 | -226 | -245 | -259 | -247 | -376 | -319 | -316 | -461 | -376 | -554 | -588 | -711 | -790 | -876 |
| Cash from investing | -480 | 769 | -579 | -475 | -745 | -2,186 | -887 | -1,010 | -1,921 | -5,041 | -411 | -1,597 | -2,011 | -2,574 | -5,687 | -2,640 |
| Payments for dividends | - | - | - | - | - | - | - | - | - | - | 28 | 55 | 55 | 28 | - | - |
| Repurchases of common stock | - | 492 | 600 | 500 | 125 | - | - | - | - | - | 535 | - | - | - | - | - |
| Repayments of term debt | - | 1,250 | 10 | 1,450 | - | 1,150 | 250 | 1,000 | 602 | 3,560 | - | - | - | - | - | - |
| Cash from financing | -496 | -1,721 | -744 | -596 | -150 | 1,322 | -206 | 110 | 1,432 | 2,973 | 293 | -95 | -548 | 5 | 1,814 | -395 |
| Free cash flow | ||||||||||||||||
| FCF margin (%) |